Plasma concentrations of proinflammatory cytokines IL-1 and IL-6 increase in patients with depression (6); in patients taking antidepressant medications, reduction of plasma IL-1β appears to be associated with the treatment (7). Here, IL1B is linked to depressive symptom measurement.